NDC properties for "timolol 5 MG/ML (as timolol hemihydrate 5.12 MG/ML) Ophthalmic Solution" (RxCUI 2702393)
About this data
The tables show NDC propoerties for timolol 5 MG/ML (as timolol hemihydrate 5.12 MG/ML) Ophthalmic Solution with the RxCUI 2702393
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for timolol 5 MG/ML (as timolol hemihydrate 5.12 MG/ML) Ophthalmic Solution (RxCUI 2702393)
| ANDA | ANDA216654 |
|---|---|
| MMSL_CODE | BD3325 |
| MMSL_CODE | CD3325 |
| RxCUI | 2702393 |
| SPL_SET_ID | cebc9a5e-0bdb-4f23-9b2c-cde543b62fb6 |
| VUID | 4002856 |
| Prescribable Synonym | timolol hemihydrate 0.5 % Ophthalmic Solution |
| RXNAV_STR | timolol hemihydrate 5 MG/ML Ophthalmic Solution |
| RxNorm Name | timolol hemihydrate 5 MG/ML Ophthalmic Solution |
| RxNorm Synonym | timolol 5 MG/ML (as timolol hemihydrate 5.12 MG/ML) Ophthalmic Solution |
| Related queries | Interactions (for RxCUI 2702393) |
NDC Properties
NDC Item 70069069601
| NDC 9 | 70069-696 |
|---|---|
| NDC 10 | 70069-696-01 |
| NDC Item | 70069069601 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-696-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-696 |
NDC Item 70069069701
| NDC 9 | 70069-697 |
|---|---|
| NDC 10 | 70069-697-01 |
| NDC Item | 70069069701 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-697-01) / 10 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-697 |
NDC Item 70069069801
| NDC 9 | 70069-698 |
|---|---|
| NDC 10 | 70069-698-01 |
| NDC Item | 70069069801 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-698-01) / 15 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-698 |
NDC Item 70069069601
| NDC 9 | 70069-696 |
|---|---|
| NDC 10 | 70069-696-01 |
| NDC Item | 70069069601 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-696-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-696 |
NDC Item 70069069701
| NDC 9 | 70069-697 |
|---|---|
| NDC 10 | 70069-697-01 |
| NDC Item | 70069069701 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-697-01) / 10 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-697 |
NDC Item 70069069801
| NDC 9 | 70069-698 |
|---|---|
| NDC 10 | 70069-698-01 |
| NDC Item | 70069069801 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-698-01) / 15 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-698 |
NDC Item 70069069601
| NDC 9 | 70069-696 |
|---|---|
| NDC 10 | 70069-696-01 |
| NDC Item | 70069069601 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-696-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-696 |
NDC Item 70069069701
| NDC 9 | 70069-697 |
|---|---|
| NDC 10 | 70069-697-01 |
| NDC Item | 70069069701 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-697-01) / 10 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-697 |
NDC Item 70069069801
| NDC 9 | 70069-698 |
|---|---|
| NDC 10 | 70069-698-01 |
| NDC Item | 70069069801 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-698-01) / 15 mL in 1 BOTTLE |
| ANDA | ANDA216654 |
| FDA SPL set id | 827154 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-698 |